The blockade of the endocannabinoid CB1 receptors and its influence on cardiometabolic risk: Lesson from Rimonabant In Obesity (RIO) trials

✍ Scribed by Roberto Vettor; Marco Rossato; Francesco Fallo; Claudio Pagano

• Book ID: 119257999
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 184 KB
• Volume: 1303
• Category: Article
• ISSN: 0531-5131
• DOI: 10.1016/j.ics.2007.03.025